xYjSNe9N4B4XoE12GRSprqcOvpLxjVgFYV0cofNXSHnB1AzmUEzVZfNDAGtd

Paper Publications

Home >> Scientific Research >> Paper Publications

BET bromodomain inhibition blocks an AR-Repressed, E2F1-Activated treatment-emergent neuroendocrine prostate cancer lineage plasticity program

Release Time:2021-12-01| Hits:

Title of Paper:BET bromodomain inhibition blocks an AR-Repressed, E2F1-Activated treatment-emergent neuroendocrine prostate cancer lineage plasticity program

Journal:Clinical Cancer Research

Translation or Not:No

Date of Publication:2021-10

Release Time:2021-12-01

Prev One:
Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes
Next One:
Discovering cooperative biomarkers for heterogeneous complex disease diagnoses

中文    |   MOBILE Version   |   Login   |   SDU   

Copyright All Rights Reserved Shandong University Address: No. 27 Shanda South Road, Jinan City, Shandong Province, China: 250100
Information desk: (86) - 0531-88395114
On Duty Telephone: (86) - 0531-88364731 Construction and Maintenance: Information Work Office of Shandong University

Click: Times

The Open Time: --

The Last Update Time: --